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Malignant peripheral nerve sheath tumors (MPNSTs) are rare sarcomas that are strongly associated with
neuroﬁbromatosis type I (NF-1). We describe a 71-year-old woman with no stigmata of neuroﬁbroma-
tosis, who presented with recurrent subcutaneous tumor on her left upper back. She received two
excisional biopsies on the back of her trunk at our hospital and both pathology reports revealed neu-
roﬁbromas. Three years after the last skin biopsy, a rapidly growing subcutaneous tumor emerged at the
same site. This tumor was totally resected and the histopathology showed an ill-deﬁned tumor in the
dermis and subcutaneous tissue. The tumor was composed of spindle cells in a myxoid stroma with a
transition from the area of typical neuroﬁbroma to the hypercellular area. The hypercellular area con-
sisted of atypical, hyperchromatic spindled cells with frequent mitotic ﬁgures. She was therefore diag-
nosed with MPNST.
Copyright  2013, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Malignant peripheral nerve sheath tumors (MPNSTs; also known as
“malignant schwannoma”, “neuroﬁbrosarcoma”, and “neuro-
sarcoma”) are rare neoplasms of ectomesenchymal origin,1 with an
incidence of 0.001% in the general population.2 Approximately 50%
of cases are associated with neuroﬁbromatosis type I (NF-1).2 Most
MPNSTs are found in deep soft tissue along the major peripheral
nerve trunk. However, superﬁcial forms of this tumor have been
identiﬁed.3e6 Superﬁcial MPNST is deﬁned as a lesion predomi-
nantly located in the dermis or subcutis without contact with the
fascia.4 Some authors have suggested that the association with NF-
1 is less common in superﬁcial forms of MPNST than in their deep
counterparts.4 Most NF1-associated MPNSTs appear to arise within
pre-existing plexiform neuroﬁbromas, which are deeply seated.7
Non-NF-1 MPNSTs in association with a solitary neuroﬁbroma
and presenting as a superﬁcial form have been identiﬁed.5,6,8y have no ﬁnancial or non-
tter or materials discussed in
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ng).
iwanese Dermatological AssociatioHerein, we report a case of MPNST arising in a location of previ-
ously diagnosed recurrent neuroﬁbroma.
Case report
A 71-year-old woman presented to our clinic with a 2.5  1.5 cm
skin-colored tumor on her left upper back in May 2009
(Figure 1A). She had no clinical signs of NF-1, such as café-au-lait
spots, axillary freckling, multiple cutaneous neuroﬁbromas, and
iris hamartomas (Lisch nodules) on physical examination. A family
history of NF-1 or past history of radiation exposure were absent.
An excisional biopsy showed some mucinous material admixed
with faintly eosinophilic collagen extending in various directions,
interlaced with spindle cells with elongated wavy nuclei in the
dermis (Figure 1B and C). The spindle cells were positive for S-100
and neuroﬁbroma was diagnosed (Figure 1D). There was recur-
rence of the skin tumor at the same site 9 months later
(Figure 2A). Another excisional biopsy was done and showed a
myxoid tumor embedded in thick collagen bundles in the mid to
deep dermis. The tumor consisted of spindle cells with elongated
wavy nuclei arranged in a whorled pattern and faintly eosinophilic
collagen in myxoid stroma (Figure 2B and C). The spindle cells
were positive for S-100 (Figure 2D). Recurrent neuroﬁbroma was
diagnosed. Three years later, a rapidly growing skin tumor
emerged at the same site (Figure 3A). The patient received totaln. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 (A) A 2.5 cm  1.5 cm skin-colored tumor on the left upper back. (B,C) Skin biopsy showed some mucinous material admixed with faintly eosinophilic collagen extending
in various directions, interlaced with spindle cells with elongated wavy nuclei in the dermis [hematoxylin and eosin; original magniﬁcation: (B) 20, (C) 400]. (D) The tumor cells
showed positive staining for S-100 [immunohistochemical staining; original magniﬁcation: (D) 100].
Figure 2 (A) Recurrence of skin tumor at previous biopsy site, measuring about 3.0 cm  2.5 cm. (B,C) Skin biopsy showed spindle cells with elongated wavy nuclei arranged in a
whorled pattern admixed with faintly eosinophilic collagen in a myxoid stroma [hematoxylin and eosin; original magniﬁcation: (B) 20, (C) 400]. (D) The tumor cells showed
positive staining for S-100 [immunohistochemical staining; original magniﬁcation: (D) 100].
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Figure 3 (A) A 5 cm  8 cm skin tumor arising from a previous biopsy site. (B) Diffuse inﬁltration of tumor cells in the upper dermis to subcutaneous tissue with focal myxoid
change. (C) A transition from a densely cellular area at the lower right to a typical neuroﬁbroma at the upper left [hematoxylin and eosin; original magniﬁcation: (B) 4, (C) 40].
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deﬁned tumor in the dermis and subcutaneous tissue, measuring
5 cm  3.8 cm  3.5 cm (Figure 3B). Microscopically, the tumor
was composed of spindle cells in a focally myxoid stroma with an
obvious transition from the area of typical neuroﬁbroma to theFigure 4 (A) There was an obvious transition from an area of typical neuroﬁbroma at the lo
tumor consisted of atypical, hyperchromatic spindle cells with frequent mitotic ﬁgures [hem
showed positive staining for S-100 [immunohistochemical staining; original magniﬁcation:hypercellular area (Figures 3C and 4A). The hypercellular area
consisted of atypical, hyperchromatic spindled cells with frequent
mitotic ﬁgures (Figure 4B). Immunohistochemical staining
revealed that the tumor cells were positive for S-100 (Figure 4C
and D). Based on these ﬁndings, we made a diagnosis of superﬁcialwer right to the hypercellular area at the upper left. (B) The hypercellular areas of the
atoxylin and eosin; original magniﬁcation: (A) 100, (B) 400]. (C,D) The tumor cells
(C) 40; (D) 100].
Table 1 Histopathological and immunohistochemical features of spindle cell neoplasms.
Tumor type Histopathology Immunohistochemistrya
Gross ﬁndings Microscopic ﬁndings Cytokeratin S-100 EMA Desmin SMA
MPNST14 Irregular contours; arising
in a major nerve or preexisting
neuroﬁbroma
Fascicles of alternating cellularity;
myxoid change may be prominent;
perivascular whirling by tumor cell
and hyaline nodules can be seen
occasionally
e þ þ/e NA NA
Cutaneous
leiomyosarcoma15
Ill-deﬁned, diffuse inﬁltration Interlacing bundles of tumor cells
with eosinophilic cytoplasm and
cigar-shaped, vesicular nuclei;
nuclear palisading can be seen
occasionally
e/þ e/þ NA þ/e þ
Monophasic synovial
sarcoma16
Variable Well-oriented, uniform spindle
cells with tapering nuclei; focal
herringbone pattern; focal
hemangiopericytomatous vessels
þ/e þ/e þ e/þ e/þ
Adult ﬁbrosarcoma17 Well-circumscribed Extensive herringbone pattern;
no hemangiopericytomatous vessels
e e e e þ, Focal
EMA ¼ epithelial membrane antigen; MPNST ¼ malignant peripheral nerve sheath tumor; NA ¼ no available data; SMA ¼ smooth muscle antigen.
a þ, expected ﬁnding in >75% of cases; þ/e, expected ﬁnding in 25e75% of cases; e/þ, may be positive, but <25% of cases; e, never positive.
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were close to the tumor cells (2e3 mm). No further follow-up
information is available owing to the recent diagnosis.Discussion
According to the World Health Organization (WHO) deﬁnition,
MPNSTs are malignant tumors arising from a peripheral nerve or
extraneural soft tissue with nerve sheath differentiation.9
Approximately 50% of MPNSTs are associated with NF-1 with the
remainder occurring sporadically. The incidence of MPNST among
patients with NF-1 is approximately 10%.2 In patients with NF-1,
MPNSTs often arise within pre-existing neuroﬁbromas, in partic-
ular deep plexiform neuroﬁbromas.10 Radiation exposure is
another risk factor for the development of MPNST.11 A superﬁcial
form of MPNSTs with a cutaneous or subcutaneous origin has been
identiﬁed, and association with solitary neuroﬁbromas was
observed.4e6,8,12 It has been demonstrated that loss of functional
NF1 allele in a Schwann cell may be the initial step in neuroﬁ-
broma pathogenesis, and subsequent progression from neuroﬁ-
broma to MPNST is associated with additional molecular
alterations.13 However, several key steps in this process remain
poorly understood.
The diagnosis of MPNST is sometimes difﬁcult due to the his-
topathological similarities with other spindle cell sarcomas, such as
monophasic synovial sarcoma, leiomyosarcoma, and ﬁbrosar-
coma.2 A combination of gross, histopathological, and immuno-
histochemical studies can be helpful in making the diagnosis
(Table 1).14e17 Notably, each of these tumors has multiple different
variants with atypical morphological characteristics and staining
properties. For MPNSTs, neural markers of S-100, CD56, and protein
gene product 9.5 (PGF 9.5) have been considered as sensitive
markers. S-100, traditionally regarded as the best marker, was
found to be expressed in only 50e90% of the MPNSTs.18 The tumor
that perhaps most closely resembles MPNSTs is synovial sarcoma.19
Synovial sarcomas may involve nerves and MPNSTs may show
glandular pattern. A history of NF1 and/or a co-existing neuroﬁ-
broma precursor will aid in the diagnosis of MPNST.19
The prognosis is poor for the deep counterpart of MPNSTand the
reported crude 2-year and 5-year survival rates were 57% and 39%,
respectively.20 A recent literature reviewed 13 reported cases of
superﬁcial MPNST arising in sporadic neuroﬁbroma that demon-
strated six cases with local recurrence and two cases with lung
metastases. Within the two distantly-metastatic cases, one died oftumor and the other had no follow-up after the metastases were
found. Surgical resection is the mainstay treatment, but there is no
available guideline regarding how much the margin should be
resected around the tumor.20,21
In our case, superﬁcial MPNST, which suggested an association
with solitary neuroﬁbroma, occurred in the location originally
diagnosed as recurrent neuroﬁbroma. Superﬁcial MPNSTs are a rare
variant of MPNSTs, and the lack of association with neuroﬁbro-
matosis may result in superﬁcial MPNST being overlooked. Super-
ﬁcial MPNST should be considered in the differential diagnosis of
soft tissue malignancy of the skin, especially when there is a rapidly
growing tumor arising from pre-existing neuroﬁbroma.References
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